Stock UTHR UNITED THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases United Therapeutics Corporation

Equities

UTHR

US91307C1027

Real-time Estimate Cboe BZX
Other stock markets
 11:59:14 2024-05-08 EDT 		5-day change 1st Jan Change
262.1 USD -1.56% Intraday chart for United Therapeutics Corporation +2.63% +19.09%
05-07 United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing MT
05-06 United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
United Therapeutics: Q1 Earnings Snapshot
AQ
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
BU
UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT
AQ
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
BU
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
BU
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
BU
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
BU
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
BU
The Printed Future Of Transplantology, Or How Science Fiction Became Reality
AQ
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
BU
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
BU
United Therapeutics: Q4 Earnings Snapshot
AQ
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
BU
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
BU
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
BU
Spotlight On Upcoming Oral Arguments – February 2024
AQ
Federal Circuit Evaluates Impact Of The Final Written Decision (FWD) In A Parallel Inter-Partes Review (IPR) On District Court's Decision Of Invalidity And Infringement
AQ
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BU
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
BU
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. News United Therapeutics Corporation
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW